CapForce IBD Breakout Opportunities ETF
BOUT
12 hedge funds and large institutions have $2.31M invested in CapForce IBD Breakout Opportunities ETF in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
18% more capital invested
Capital invested by funds: $1.97M → $2.31M (+$346K)
1.51% more ownership
Funds ownership: 10.44% → 11.95% (+1.5%)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
+$387K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$129K |
| 3 |
APA
American Portfolios Advisors
Holbrook,
New York
|
+$27.6K |
| 4 |
AIP
Ahrens Investment Partners
Lafayette,
Louisiana
|
+$15.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$152K |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$116K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$104K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$54K |
| 5 |
CFA
Cahill Financial Advisors
Edina,
Minnesota
|
-$39K |
BOUT Hedge Fund Activity: Q4 2021 in Review
12 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD Breakout Opportunities ETF (BOUT) for Q4 2021, worth a combined $2.31M — up 18% from $1.97M a quarter earlier.
Fund positioning in BOUT was balanced in Q4 2021: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was Wealthcare Advisory Partners, opening a new position worth an estimated $387K. The largest seller was Citadel Advisors, cutting an estimated $152K.
- 12 institutional investors held CapForce IBD Breakout Opportunities ETF (BOUT) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $2.31M of CapForce IBD Breakout Opportunities ETF stock for Q4 2021, up 18% quarter-over-quarter.
- 2 funds opened new CapForce IBD Breakout Opportunities ETF positions in Q4 2021 and 2 closed out, a net change of 0 holders.
- The largest CapForce IBD Breakout Opportunities ETF buyer in Q4 2021 was Wealthcare Advisory Partners, an estimated $387K added.
- The largest CapForce IBD Breakout Opportunities ETF seller in Q4 2021 was Citadel Advisors, an estimated $152K sold.
Based on aggregated 13F filings for Q4 2021.